FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048296859> ?p ?o ?g. }

• W3048296859 endingPage "1965" @default.
• W3048296859 startingPage "1955" @default.
• W3048296859 abstract "Patients with chronic obstructive pulmonary disease (COPD) are at risk of developing cardiac arrhythmias and elevated heart rate. A theoretical mechanistic association based on the interaction of long-acting β2-agonists (LABAs) with adrenoreceptors in the heart and vasculature is assumed as a potential class-related risk. Therefore, we performed a pooled analysis of Holter electrocardiogram (ECG) data from four 48-week, randomized, double-blind, placebo-controlled, parallel-group, Phase III clinical trials evaluating olodaterol (5 μg or 10 μg) or formoterol (12 µg) versus placebo.We analyzed Holter ECG data from a representative subset of 775 patients with Global Initiative for Chronic Obstructive Lung Disease stage 2-4 COPD from four studies (1222.11-14) assessing olodaterol (5 μg and 10 μg) and formoterol (12 µg) versus placebo.No statistically significant (P>0.3) or clinically relevant differences in the shift from baseline of premature supraventricular or ventricular beats were observed among the active treatment and the placebo groups. Minor and transient differences were observed in the adjusted mean heart rate from baseline during treatment in all groups. There was a numerically small but statistically significant increase for formoterol at Week 24, olodaterol 5 μg at Weeks 12 and 40, and olodaterol 10 μg at Week 40 (all less than 3.0 beats per minute). Mean heart rates returned to a statistically non-significant change at Week 48 for all treatment groups. No increase in major adverse cardiovascular events was observed.Treatment with olodaterol or formoterol is not associated with arrhythmias or a persistent increase in heart rate as assessed by Holter ECG in patients with COPD.ClinicalTrials.gov identifiers: NCT00782210 (1222.11); NCT00782509 (1222.12); NCT00793624 (1222.13); NCT00796653 (1222.14)." @default.
• W3048296859 created "2020-08-13" @default.
• W3048296859 creator A5009000391 @default.
• W3048296859 creator A5026619386 @default.
• W3048296859 creator A5036109929 @default.
• W3048296859 creator A5065946882 @default.
• W3048296859 creator A5072700645 @default.
• W3048296859 creator A5082448702 @default.
• W3048296859 date "2020-08-01" @default.
• W3048296859 modified "2023-10-02" @default.
• W3048296859 title "<p>A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD</p>" @default.
• W3048296859 cites W1914898633 @default.
• W3048296859 cites W1996275057 @default.
• W3048296859 cites W2003693083 @default.
• W3048296859 cites W2035897478 @default.
• W3048296859 cites W2038697731 @default.
• W3048296859 cites W2039075810 @default.
• W3048296859 cites W2048113092 @default.
• W3048296859 cites W2060873423 @default.
• W3048296859 cites W2068362303 @default.
• W3048296859 cites W2069879981 @default.
• W3048296859 cites W2085884784 @default.
• W3048296859 cites W2088477168 @default.
• W3048296859 cites W2109535739 @default.
• W3048296859 cites W2111044854 @default.
• W3048296859 cites W2111722183 @default.
• W3048296859 cites W2116533609 @default.
• W3048296859 cites W2118228748 @default.
• W3048296859 cites W2134122420 @default.
• W3048296859 cites W2164281047 @default.
• W3048296859 cites W2194957814 @default.
• W3048296859 cites W2233753101 @default.
• W3048296859 cites W2289999025 @default.
• W3048296859 cites W2511146965 @default.
• W3048296859 cites W2750520206 @default.
• W3048296859 cites W2782011123 @default.
• W3048296859 cites W2788412143 @default.
• W3048296859 cites W2792599624 @default.
• W3048296859 cites W2794058912 @default.
• W3048296859 cites W2809422875 @default.
• W3048296859 cites W2887621146 @default.
• W3048296859 cites W2895246789 @default.
• W3048296859 cites W2974492377 @default.
• W3048296859 cites W2992624131 @default.
• W3048296859 cites W3028459339 @default.
• W3048296859 doi "https://doi.org/10.2147/copd.s246353" @default.
• W3048296859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7428408" @default.
• W3048296859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32848381" @default.
• W3048296859 hasPublicationYear "2020" @default.
• W3048296859 type Work @default.
• W3048296859 sameAs 3048296859 @default.
• W3048296859 citedByCount "4" @default.
• W3048296859 countsByYear W30482968592020 @default.
• W3048296859 countsByYear W30482968592022 @default.
• W3048296859 countsByYear W30482968592023 @default.
• W3048296859 crossrefType "journal-article" @default.
• W3048296859 hasAuthorship W3048296859A5009000391 @default.
• W3048296859 hasAuthorship W3048296859A5026619386 @default.
• W3048296859 hasAuthorship W3048296859A5036109929 @default.
• W3048296859 hasAuthorship W3048296859A5065946882 @default.
• W3048296859 hasAuthorship W3048296859A5072700645 @default.
• W3048296859 hasAuthorship W3048296859A5082448702 @default.
• W3048296859 hasBestOaLocation W30482968591 @default.
• W3048296859 hasConcept C126322002 @default.
• W3048296859 hasConcept C142724271 @default.
• W3048296859 hasConcept C164705383 @default.
• W3048296859 hasConcept C204787440 @default.
• W3048296859 hasConcept C27081682 @default.
• W3048296859 hasConcept C2776042228 @default.
• W3048296859 hasConcept C2776136866 @default.
• W3048296859 hasConcept C2776780178 @default.
• W3048296859 hasConcept C2777953023 @default.
• W3048296859 hasConcept C2779871671 @default.
• W3048296859 hasConcept C2780040984 @default.
• W3048296859 hasConcept C2780074459 @default.
• W3048296859 hasConcept C42219234 @default.
• W3048296859 hasConcept C67761136 @default.
• W3048296859 hasConcept C71924100 @default.
• W3048296859 hasConcept C84393581 @default.
• W3048296859 hasConceptScore W3048296859C126322002 @default.
• W3048296859 hasConceptScore W3048296859C142724271 @default.
• W3048296859 hasConceptScore W3048296859C164705383 @default.
• W3048296859 hasConceptScore W3048296859C204787440 @default.
• W3048296859 hasConceptScore W3048296859C27081682 @default.
• W3048296859 hasConceptScore W3048296859C2776042228 @default.
• W3048296859 hasConceptScore W3048296859C2776136866 @default.
• W3048296859 hasConceptScore W3048296859C2776780178 @default.
• W3048296859 hasConceptScore W3048296859C2777953023 @default.
• W3048296859 hasConceptScore W3048296859C2779871671 @default.
• W3048296859 hasConceptScore W3048296859C2780040984 @default.
• W3048296859 hasConceptScore W3048296859C2780074459 @default.
• W3048296859 hasConceptScore W3048296859C42219234 @default.
• W3048296859 hasConceptScore W3048296859C67761136 @default.
• W3048296859 hasConceptScore W3048296859C71924100 @default.
• W3048296859 hasConceptScore W3048296859C84393581 @default.
• W3048296859 hasLocation W30482968591 @default.
• W3048296859 hasLocation W30482968592 @default.
• W3048296859 hasLocation W30482968593 @default.

• next